Allergologie pp 95-103 | Cite as

B-Lymphozyten und der Antikörperklassenwechsel zu IgE

  • A. Radbruch
  • M. Worm

Zusammenfassung

B-Zellen entwickeln sich im Knochenmark aus hämatopoetischen Vorläuferzellen. Sie produzieren Antikörper, die zentrale Elemente des humoralen Immunsystems sind. Die Antikörper der Klassen IgM, IgD, IgG, IgA und IgE werden über verschiedene konstante Regionen in ihren schweren Ketten definiert. Sie zeigen eine unterschiedliche Gewebeverteilung und Wirkung auf Pathogene. Der Klassenwechsel entsteht durch einen Austausch der exprimierten schweren Kettencluster, z. B. von C-µ für IgM mit C-γ, C-α oder C-ε, sodass dementsprechend IgG, IgA oder IgE entsteht, wobei die antigenbindende variable Region nicht verändert wird. Die Induktion des Klassenwechsels benötigt primäre und sekundäre Signale. Signale, die einen primären Klassenwechsel induzieren, vermitteln die Expression der »activation induced cytidine deaminase« (AID) und weitere Proteine, die für den Klassenwechsel eine Rolle spielen, wie etwa den Transkriptionsfaktor NF-κΒ. Signale, die sekundär einen Klassenwechsel fördern, können die Expression von AID nicht induzieren, sind jedoch für die Steuerung des Klassenwechsels zu einem bestimmten Isotyp, wie bspw. IgG, IgA oder IgE durch die Auswahl der S-Region über die Induktion der Keimwandtranskripte, wirksam. Für IgE spielen hier die Zytokine IL-4 und IL-13 beim Menschen eine zentrale Rolle.

Literatur

  1. Akdis M, Verhagen J, Taylor A et al.(2004) Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 calls. J Exp Med 199: 1567–1575Google Scholar
  2. Angelin-Duclos C, Cattoretti G, Lin KI et al. (2000) Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J Immunol 165: 5462–5471Google Scholar
  3. Audzevich T, Pearce G, Breucha M et al. (2013) Control of the STAT6-BCL6 antagonism by SWAP-70 determines IgE production. J Immunol 190: 4946–4955Google Scholar
  4. Barton GM, Kagan JC (2009) A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol 9: 535–542Google Scholar
  5. Bilsborough J, Chadwick E, Mudri S et al. (2008) TACI-Ig prevents the development of airway hyperresponsiveness in a murine model of asthma. Clin Exp Allergy 38: 1959–1968Google Scholar
  6. Bowles SL, Jaeger C, Ferrara C et al. (2011) Comparative binding of soluble fragments (derCD23, sCD23, and exCD23) of recombinant human CD23 to CD21 (SCR 1-2) and native IgE, and their effect on IgE regulation. Cell Immunol 271: 371–378Google Scholar
  7. Cameron L, Gounni AS, Frenkiel S et al. (2003) S epsilon S mu and S epsilon S gamma switch circles in human nasal mucosa following ex vivo allergen challenge: evidence for direct as well as sequential class switch recombination. J Immunol 171: 3816–3822Google Scholar
  8. Casadevall A, Pirofski LA (2011) A new synthesis for antibody-mediated immunity. Nat Immunol 13: 21–28Google Scholar
  9. Cassese G, Arce S, Hauser AE et al. (2003) Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol 171: 1684–1690Google Scholar
  10. Cerutti A, Rescigno M (2008) The biology of intestinal immunoglobulin A responses. Immunity 28: 740–750Google Scholar
  11. Cerutti A, Chen K, Chorny A (2011) Immunoglobulin responses at the mucosal interface. Annu Rev Immunol 29: 273–293Google Scholar
  12. Chaudhuri J, Alt FW (2004) Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol 4: 541–552Google Scholar
  13. Coker HA, Durham SR, Gould HJ (2003) Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol 171: 5602–5610Google Scholar
  14. Cooper AM, Hobson PS, Jutton MR et al. (2012) Soluble CD23 controls IgE synthesis and homeostasis in human B cells. J Immunol 188: 3199–3207Google Scholar
  15. Eibel H, Salzer U, Warnatz K (2010) Common variable immunodeficiency at the end of a prospering decade: towards novel gene defects and beyond. Curr Opin Allergy Clin Immunol 10: 526–533Google Scholar
  16. Fagarasan S, Kawamoto S, Kanagawa O et al. (2010) Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol 28: 243–273Google Scholar
  17. Geha RS, Jabara HH, Brodeur SR (2003) The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 3(9): 721–732Google Scholar
  18. Gould HJ, Sutton BJ (2008) IgE in allergy and asthma today. Nat Rev Immunol 8: 205–217Google Scholar
  19. Hammad H, Lambrecht BN (2008) Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 8: 193–204Google Scholar
  20. Hasham MG, Donghia NM, Coffey E et al. (2010) Widerspread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Nat Immunol 11: 820–826Google Scholar
  21. Hawrylowicz CM, O’Garra A (2005) Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 5: 271–283Google Scholar
  22. He B, Santamaria R, Xu W et al. (2010) The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol 11: 836–845Google Scholar
  23. Holland SM, DeLeo FR, Elloumi HZ et al. (2007) STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 357: 1608–1619Google Scholar
  24. Holt PG, Sedgwick JD, O’Leary C et al. (1984) Long-lived IgE- and IgG-secreting cells in rodents manifesting persistent antibody responses. Cell Immunol 89: 281–289Google Scholar
  25. Honjo T (2008) A memoir of AID, which engraves antibody memory on DNA. Nat Immunol 9: 335–337Google Scholar
  26. Jung S, Siebenkotten G, Radbruch A (1994) Frequency of immunoglobulin E class switching is autonomously determined and independent of prior switching to other classes. J Exp Med 179: 2023–2026Google Scholar
  27. Kato A, Peters A, Suh L et al. (2008) Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunl 121: 1385–1392Google Scholar
  28. Kato A, Xiao H, Chustz RT et al. (2009) Local release of B cell-activating factor of the TNF family after segmental allergen challenge of allergic subjects. J Allergy Clin Immunol 123: 369–375Google Scholar
  29. Khan WN (2009) B cell receptor and BAFF receptor signalling regulation of B cell homeostasis. J Immunol 183: 3561–3567Google Scholar
  30. Klein U, Dalla-Favera R (2008) Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8: 22–33Google Scholar
  31. Linehan LA, Wendy D, Warren PA et al. (1998) STAT6 is required for IL-4-induced germline lg gene transcription and switch recombination. J Immunol 161: 302–10Google Scholar
  32. Liu YJ, Arpin C (1997) Germinal center development. Immunol Rev 156: 111–126Google Scholar
  33. Lloyd CM, Hawrylowicz CM (2009) Regulatory T cells in asthma. Immunity 31: 438–449Google Scholar
  34. Luger EO, Fokuhl V, Wegmann M et al. (2009) Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. J Allergy Clin Immunol 124: 819–826Google Scholar
  35. Luger EO, Wegmann M, Achatz G et al. (2010) Allergy for a lifetime? Allergol Int 59: 1–8Google Scholar
  36. Mackay F, Schneider P (2009) Cracking the BAFF code. Nat Rev Immunol 9: 491.502Google Scholar
  37. Mackay F, Figgett WA, Saulep D et al. (2010) B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor. Immunol Rev 237: 205–225Google Scholar
  38. MacLennan IC (1994) Germinal centers. Annu Rev Immunol 12: 117–139Google Scholar
  39. Manz RA, Thiel A, Radbruch A (1997) Lifetime of plasma cells in the bone marrow. Nature 388: 133–134Google Scholar
  40. McCloskey N, Hunt J, Beavil RL et al. (2007) Soluble CD23 monomers inhibit and oligomers stimulate IgE synthesis in human B cells. J Biol Chem 282: 24083–24091Google Scholar
  41. McHeyzer-Williams M, Okitsu S, Wang N et al. (2012) Molecular programming of B cell memory. Nat Rev Immunol 12: 24–34Google Scholar
  42. Mond JJ, Lees A, Snapper CM (1995) T cell-independent antigens type 2. Annu Rev Immunol13: 655–692Google Scholar
  43. Park SR, Zan H, Pal Z et al. (2009) HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation. Nature Immuno 10: 540–550Google Scholar
  44. Pasqualucci L, Bhagat G, Jankovic M et al. (2008) AID is required for germinal center-derived lymphomagenesis. Nature Genet 40: 108–112Google Scholar
  45. Pieper K, Grimbacher B, Eibel H (2013) B-cell biology and development. J Allergy Clin Immunol 131: 959–971Google Scholar
  46. Polverino F, Baraldo S, Bazzan E et al. (2010) A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family. Am J Respir Crit Care Med 182: 1011–1019Google Scholar
  47. Pone EJ, Zhang J, Mai T et al. (2012) BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway. Nature Commun 3: 767Google Scholar
  48. Radbruch A, Muehlinghaus G, Luger EO et al. (2006) Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6: 741–750Google Scholar
  49. Reimold AM, Ponath PD, Li YS et al. (1996) Trancription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. Exp Med 183: 393–401Google Scholar
  50. Saito M, Nagasawa M, Takada H et al. (2011) Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. J Exp Med 208: 235–249Google Scholar
  51. Snow RE, Djukanovic R, Stevenson FK (1999) Analysis of immunoglobulin E VH transcripts in a bronchial biopsy of an asthmatic patient confirms bias towards VH5, and indicates local clonal expansion, somatic mutation and isotype switch events. Immunology 98: 646–651Google Scholar
  52. Stavnezer J, Guikema JE, Schrader CE (2008) Mechanism and regulation of class switch recombination. Annu Rev Immunol 26: 261–292Google Scholar
  53. Takhar P, Smurthwaite L, Coker HA et al. (2005) Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. J Immunol 174: 5024–5032Google Scholar
  54. Umetsu DT, DeKruyff RH (2006) The regulation of allergy and asthma. Immunol Rev 212: 238–255Google Scholar
  55. Warnatz K, Salzer U, Rizzi M et al. (2009) B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 106: 13945–13950Google Scholar
  56. Wesemann DR, Magee JM, Boboila C et al. (2011) Immature B cells preferentially switch to IgE with increased direct Sµ to Sε recombination. J Exp Med 208: 2733–2746Google Scholar
  57. Wingren C, Hansson UB, Alkner U in Van Nostrand’s Scientific Encyclopedia (ed. Considine, G. D.) (Wiley-Interscience 2007).Google Scholar
  58. Worm M, Henz BM (1997) Molecular regulation of human IgE synthesis. J Mol Med 75(6): 440–447Google Scholar
  59. Xu Z, Zan H, Pone EJ et al. (2012) Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nature Rev Immunol 12: 517–531Google Scholar
  60. Zarnegar B, He JQ, Oganesyan G et al. (2004) Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-κB actication pathways. Proc Natl Acad Sci USA 101: 8108–8113Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • A. Radbruch
    • 1
  • M. Worm
    • 2
  1. 1.Institut der Leibniz-GemeinschaftDeutsches Rheuma-Forschungszentrum Berlin (DRFZ)BerlinDeutschland
  2. 2.Klinik für Dermatologie, Venerologie und AllergologieCharité – Universitätsmedizin BerlinBerlinDeutschland

Personalised recommendations